- Home
- MOLN vs TWIN Comparison
MOLN vs TWIN Comparison
Compare MOLN & TWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOLN
- TWIN
- Stock Information
- Founded
- MOLN 2004
- TWIN 1918
- Country
- MOLN Switzerland
- TWIN United States
- Employees
- MOLN N/A
- TWIN N/A
- Industry
- MOLN
- TWIN Industrial Machinery/Components
- Sector
- MOLN
- TWIN Industrials
- Exchange
- MOLN Nasdaq
- TWIN Nasdaq
- Market Cap
- MOLN 183.2M
- TWIN 97.0M
- IPO Year
- MOLN 2021
- TWIN N/A
- Fundamental
- Price
- MOLN $3.89
- TWIN $8.73
- Analyst Decision
- MOLN
- TWIN Strong Buy
- Analyst Count
- MOLN 0
- TWIN 1
- Target Price
- MOLN N/A
- TWIN $12.00
- AVG Volume (30 Days)
- MOLN 2.4K
- TWIN 154.6K
- Earning Date
- MOLN 08-25-2025
- TWIN 08-14-2025
- Dividend Yield
- MOLN N/A
- TWIN 1.82%
- EPS Growth
- MOLN N/A
- TWIN N/A
- EPS
- MOLN N/A
- TWIN 0.29
- Revenue
- MOLN $2,525,030.00
- TWIN $328,478,000.00
- Revenue This Year
- MOLN N/A
- TWIN $27.91
- Revenue Next Year
- MOLN $866.67
- TWIN N/A
- P/E Ratio
- MOLN N/A
- TWIN $30.14
- Revenue Growth
- MOLN N/A
- TWIN 11.49
- 52 Week Low
- MOLN $3.36
- TWIN $6.16
- 52 Week High
- MOLN $12.22
- TWIN $14.98
- Technical
- Relative Strength Index (RSI)
- MOLN 43.53
- TWIN 70.14
- Support Level
- MOLN $3.50
- TWIN $7.43
- Resistance Level
- MOLN $3.90
- TWIN $9.05
- Average True Range (ATR)
- MOLN 0.17
- TWIN 0.38
- MACD
- MOLN -0.01
- TWIN 0.13
- Stochastic Oscillator
- MOLN 12.70
- TWIN 84.97
About MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
About TWIN Twin Disc Incorporated
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.